Last reviewed · How we verify
Cortisporin (BACITRACIN)
At a glance
| Generic name | BACITRACIN |
|---|---|
| Sponsor | Pfizer |
| Drug class | bacitracin |
| Target | Tyrosine-protein kinase Lck |
| Modality | Recombinant protein |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
| First approval | 1948 |
Approved indications
- Bacterial keratitis
- Blepharoconjunctivitis
- Corneal abrasion
- Infective blepharitis
- Keratitis
- Minor Bacterial Skin Infections
- Superficial Ocular Infection
Common side effects
- Allergic contact dermatitis
- Itching
- Burning
- Irritation
- Dryness
- Folliculitis
- Acneiform eruptions
- Hypertrichosis
- Hypopigmentation
- Perioral dermatitis
- Maceration of the skin
- Skin atrophy
Serious adverse events
- Ototoxicity
- Nephrotoxicity
- Secondary infection
Key clinical trials
- Vancomycin Powder and Dilute Povidone Iodine Lavage for Infection Prophylaxis in High Risk Total Joint Arthroplasty (PHASE1)
- Nailbed Repair for Patients With Nailbed Injuries (NA)
- The Use of Medical Grade Honey in the Prevention of Bone Anchored Hearing Aid Associated Skin Breakdown (PHASE4)
- Clinical Assessment of Protopic® Ointment in Deep Partial-Thickness Burns (PHASE1)
- Impaired Risk Awareness During Intoxication in DUI Offenders (NA)
- Multi-omics Dissection of Gut Microbiome Engraftment During FMT (NA)
- The Effects of Post-Operative Interventions on Surgical Site Occurrences in AWR (NA)
- Comparison of Collagenase With Antibiotic Ointment of Minor Partial Thickness Burns (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| FDA label | Mechanism, indications, dosing, boxed warnings, drug interactions |
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |